Search

Search

Filter
621 - 630 of 1381 results

Results for

doctor talking to a patient while they both look at a tablet

Abt Global Wins Seat on CMS RMADA 3 Contract Vehicle

News
Abt Global has been awarded a seat on the Centers for Medicare & Medicaid Services’ (CMS) Research, Measurement, Assessment, Design, and Analysis 3 contract vehicle, known as RMADA 3.
man at a keyboard

Abt’s Approach to Practical AI Adoption for Government

Impact Brief
Abt’s AI advisory services help agencies move beyond pilots to AI adoption through structured implementation, strong governance, & workforce enablement.
Default image

Housing Demand and Neighborhood Choice with Housing Vouchers

Publication
Climate Impacts and Risk Assessment (CIRA) Modeling

Climate Impacts and Risk Assessment (CIRA) Modeling

Project
Abt Global’s staff has developed and implemented spatially specific modeling approaches for the U.S. Environmental Protection Agency (EPA) to quantify, and often estimate the cost of, the impacts of climate change on a number of sectors and dynamics in…
21st Century Tools for Researchers and Practitioners Using Automated Tools for Knowledge Curation

21st Century Tools for Researchers and Practitioners Using Automated Tools for Knowledge Curation

Publication
This report covers Abt-developed automated research tools for 21st century knowledge curation to quickly examine vast amounts of information within a domain.
Evaluating the CQWBSC PHN’s Coordination of the GPLO Network

Evaluating the CQWBSC PHN’s Coordination of the GPLO Network

Project
The General Practitioner Liaison Officer (GPLO) Network aims to strengthen the link between Health and Hospital Services (HHSs) and general practice by identifying service gaps and improving the communication, the integration of services, and the…
Evaluating the Cell and Gene Therapy Access Model

Evaluating the Cell and Gene Therapy Access Model

Project
The Centers for Medicare & Medicaid Services created the Cell and Gene Therapy Access Model to be able to negotiate with manufacturers on behalf of states to make high-cost specialty drugs available to beneficiaries and affordable to State Medicaid Agencies.